Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Online-Ressource
    Online-Ressource
    Wiley ; 2017
    In:  Journal of Cutaneous Pathology Vol. 44, No. 9 ( 2017-09), p. 740-746
    In: Journal of Cutaneous Pathology, Wiley, Vol. 44, No. 9 ( 2017-09), p. 740-746
    Kurzfassung: Merkel cell carcinoma ( MCC ) is an aggressive neoplasm, which is often associated with Merkel cell polyomavirus ( MCPyV ). Programmed death‐1 ( PD ‐1) and its ligand PD‐L1 are key players of the tumor microenvironment ( TME ). Methods Fourteen paraffin‐embedded tissue samples of MCC were stratified by their MCPyV detection. Apart from PD‐L1 and PD ‐1, the TME was further characterized for the expression of CD33 , FOXP3 and MxA . Results We observed PD ‐1 in 2 of 12 tumors. PD‐L1 expression by tumor cells was found in 7 of 8 MCPyV (+) samples and was detected particularly in the periphery. The tumor cells were surrounded by a shield of PD‐L1 / CD33 immune cells. Expression of PD‐L1 by the tumor cells was higher in areas with a denser immune infiltrate. CD33 (+) cells without direct tumor contact were PD‐L1 negative. Only a low number of FOXP3 (+) regulatory T‐cells was admixed. Tumor cells of MCPyV (−) samples were mostly PD‐L1 negative. Conclusions Our data demonstrate that PD‐L1 expression occurs in tumor and immune cells, in areas in which they are close in contact. Interferon seems to play a role in this interaction. We postulate that PD‐L1 (+)/ CD33 (+) cells shield the tumor against attacking PD ‐1(+) immune cells. Therefore, next to anti‐ PD ‐1/ PD‐L1 antibodies, blockade of CD33 seems to be a promising therapeutic approach.
    Materialart: Online-Ressource
    ISSN: 0303-6987 , 1600-0560
    URL: Issue
    Sprache: Englisch
    Verlag: Wiley
    Publikationsdatum: 2017
    ZDB Id: 2018100-0
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz